Cancer immunotherapy research departments need to break their obsession with the latest flavour of the month - checkpoint inhibitors -...
Read moreOn Friday, June 06, 2014, the NASDAQ Composite ended at 4,321.40, up 0.59%, the Dow Jones Industrial Average finished the...
Read moreAs of January 2014, the EMA lifted the restriction on providing fee reductions to large companies developing new orphan drugs...
Read moreProvence Technologies acquires SynprosisThe acquisition strengthens Provence Technologies’ expertise in its core business of therapeutic chemistry Provence Technologies Group, a...
Read moreThe Orphan Drugs Market is set to Rise as a Result of Pharma Companies now Looking to Orphan Drugs as...
Read morePolyplus-transfection SA, a privately-held company specializing in the development of innovative solutions for transfection, today announces the launch of FectoPRO(TM),...
Read moreA Phase IIa clinical study will test the efficacy, safety and tolerability profile Ferrer, a privately-held Spanish pharmaceutical company, today announces...
Read moreFrench pharmaceutical firm Sanofi and Germany-based Fraunhofer-Gesellschaft have formed a natural product center of excellence to speed up the discovery...
Read moreGalena Biopharma and Dr. Reddy's Laboratories have entered into a strategic development and commercialization partnership on NeuVax (nelipepimut-S) in India....
Read moreCellceutix, a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications, today provides shareholders with an...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
